Insider · CIK 0001292834
David P Hochman
officerdirector
Files at OBIO (Orchestra BioMed Holdings, Inc.). First filing Dec 19, 2024, latest Sep 8, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
7 / 0
$224k bought, $0 sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
OBIO: Orchestra BioMed Holdings, Inc.
OBIOOct 9, 2026 · close 5.95
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 17Weak | OBIObuy Orchestra BioMed Holdings, Inc. | $48k 10,000 shares | +1% | - | |
| 20Weak | OBIObuy Orchestra BioMed Holdings, Inc. | $43k 10,000 shares | +1% | +79% from low-22% from high | |
| 23Weak | OBIObuy Orchestra BioMed Holdings, Inc. | $20k 5,000 shares | +1% | +68% from low-37% from high | |
| 48Moderate | Orchestra BioMed Holdings, Inc. | $15k 6,000 shares | +1% | +3% from low-61% from high | |
| 41Moderate | Orchestra BioMed Holdings, Inc. | $55k 20,000 shares | +6% | +11% from low-58% from high | |
| 23Weak | Orchestra BioMed Holdings, Inc. | $19k 4,000 shares | +1% | - | |
| 18Weak | Orchestra BioMed Holdings, Inc. | $25k 5,000 shares | +1% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 10, 2026 | OBIO Orchestra BioMed Holdings, Inc. | FTax withholding Common Stock, par value $0.0001 per share ("Common Stock") | -3,283 | $5.81 | $19k | 1,067,463 | 31 d ago |
| Sep 10, 2026 | OBIO Orchestra BioMed Holdings, Inc. | FTax withholding Common Stockindirect: By the DPH 2008 Trust | -3,283 | $5.81 | $19k | 432,916 | 31 d ago |
| Sep 3, 2026 | OBIO Orchestra BioMed Holdings, Inc. | POpen-market purchase Common Stock, par value $0.0001 per share ("Common Stock") | +10,000 | $4.79 | $48k | 1,070,746 | 34 d ago |
| Mar 25, 2026 | OBIO Orchestra BioMed Holdings, Inc. | FTax withholding Common Stock, par value $0.0001 per share ("Common Stock") | -32,438 | $4.57 | $148k | 1,054,029 | Mar 27, 2026 |
| Mar 13, 2026 | OBIO Orchestra BioMed Holdings, Inc. | POpen-market purchase Common Stock, par value $0.0001 per share ("Common Stock") | +10,000 | $4.29 | $43k | 1,086,467 | Mar 16, 2026 |
| Feb 12, 2026 | OBIO Orchestra BioMed Holdings, Inc. | AGrant or award Common Stock, par value $0.0001 per share ("Common Stock") | +504,000 | $0.00 | $0 | 1,076,467 | Feb 13, 2026 |
| Dec 10, 2025 | OBIO Orchestra BioMed Holdings, Inc. | FTax withholding Common Stock, par value $0.0001 per share ("Common Stock") | -40,355 | $4.67 | $188k | 572,467 | Dec 12, 2025 |
| Dec 10, 2025 | OBIO Orchestra BioMed Holdings, Inc. | FTax withholding Common Stockindirect: By the DPH 2008 Trust | -3,283 | $4.67 | $15k | 439,482 | Dec 12, 2025 |
| Nov 14, 2025 | OBIO Orchestra BioMed Holdings, Inc. | POpen-market purchase Common Stock, par value $0.0001 per share ("Common Stock") | +5,000 | $4.07 | $20k | 612,822 | Nov 17, 2025 |
| Nov 13, 2025 | OBIO Orchestra BioMed Holdings, Inc. | FTax withholding Common Stock, par value $0.0001 per share ("Common Stock") | -3,283 | $4.18 | $14k | 607,822 | Nov 14, 2025 |
| Nov 13, 2025 | OBIO Orchestra BioMed Holdings, Inc. | FTax withholding Common Stockindirect: By the DPH 2008 Trust | -3,283 | $4.18 | $14k | 442,765 | Nov 14, 2025 |
| Sep 17, 2025 | OBIO Orchestra BioMed Holdings, Inc. | FTax withholding Common Stock, par value $0.0001 per share ("Common Stock") | -40,355 | $2.46 | $99k | 611,105 | Sep 19, 2025 |
| Sep 17, 2025 | OBIO Orchestra BioMed Holdings, Inc. | FTax withholding Common Stockindirect: By the DPH 2008 Trust | -3,283 | $2.46 | $8,076 | 446,048 | Sep 19, 2025 |
| Aug 21, 2025 | OBIO Orchestra BioMed Holdings, Inc. | POpen-market purchase Common Stock, par value $0.0001 per share ("Common Stock") | +6,000 | $2.49 | $15k | 651,460 | Aug 25, 2025 |
| Aug 7, 2025 | OBIO Orchestra BioMed Holdings, Inc. | AGrant or award Common Stock, par value $0.0001 per share ("Common Stock") | +100,000 | $0.00 | $0 | 645,460 | Aug 8, 2025 |
| Aug 7, 2025 | OBIO Orchestra BioMed Holdings, Inc. | AGrant or award Common Stockindirect: By the DPH 2008 Trust | +100,000 | $0.00 | $0 | 449,331 | Aug 8, 2025 |
| Aug 4, 2025 | OBIO Orchestra BioMed Holdings, Inc. | POpen-market purchase Common Stock, par value $0.0001 per share ("Common Stock")indirect: By the DPH 2008 Trust | +20,000 | $2.75 | $55k | 349,331 | Aug 4, 2025 |
| Jun 11, 2025 | OBIO Orchestra BioMed Holdings, Inc. | FTax withholding Common Stock, par value $0.0001 per share ("Common Stock") | -34,038 | $3.14 | $107k | 545,460 | Jun 13, 2025 |
| Jun 11, 2025 | OBIO Orchestra BioMed Holdings, Inc. | FTax withholding Common Stockindirect: By the DPH 2008 Trust | -5,671 | $3.14 | $18k | 329,331 | Jun 13, 2025 |
| Apr 4, 2025 | OBIO Orchestra BioMed Holdings, Inc. | AGrant or award Common Stock, par value $0.0001 per share ("Common Stock") | +98,333 | $0.00 | $0 | 579,498 | Apr 4, 2025 |
| Apr 4, 2025 | OBIO Orchestra BioMed Holdings, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +147,500 | $0.00 | $0 | 147,500 | Apr 4, 2025 |
| Mar 7, 2025 | OBIO Orchestra BioMed Holdings, Inc. | FTax withholding Common Stock, par value $0.0001 per share ("Common Stock") | -80,080 | $4.23 | $339k | 499,418 | Mar 7, 2025 |
| Dec 23, 2024 | OBIO Orchestra BioMed Holdings, Inc. | POpen-market purchase Common Stock, par value $0.0001 per share ("Common Stock") | +4,000 | $4.66 | $19k | 579,498 | Dec 26, 2024 |
| Dec 18, 2024 | OBIO Orchestra BioMed Holdings, Inc. | POpen-market purchase Common Stock, par value $0.0001 per share ("Common Stock") | +5,000 | $4.91 | $25k | 575,498 | Dec 19, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.